Low-Dose Mifepristone Inhibits Endometrial Proliferation and Up-Regulates Androgen Receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2491-2497

  Narvekar, Nitish ^a   Cameron, Sharon ^a   Critchley, Hilary O D ^a   Lin, Suiqing ^b   Cheng, Linan ^b   Baird, David T ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b International Peace Maternity and Child Health Hospital   (China)

^c Chancellor's Building   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; MIFEPRISTONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ESTROGEN ACTIVITY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; LOW DRUG DOSE; MITOSIS; OVARY FOLLICLE DEVELOPMENT; OVULATION INHIBITION; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CELL DIVISION; CONTRACEPTIVES, ORAL, SYNTHETIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; FEMALE; HISTONES; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; MITOSIS; PHOSPHORYLATION; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TIME FACTORS; UP-REGULATION;

EID: 2442464689     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031945     Document Type: Article

References (49)

1. Baird DT 2000 Clinical uses of antiprogestogens. J Soc Gynecol Invest 7:S49-S52
2. Ulmann A 2000 The development of mifepristone: a pharmaceutical drama in three acts. J Am Med Womens Assoc 55:117-120
3. Sitruk-Ware R 2000 Approval of mifepristone (RU 486) in Europe. Zentralbl Gynakol 122:241-247
4. Brown A, Cheng L, Lin S, Baird DT 2002 Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days. J Clin Endocrinol Metab 87:63-70
5. Cameron ST, Critchley HO, Thong KJ, Buckley CH, Williams AR, Baird DT 1996 Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum Reprod 11:2518-2526
6. Baird DT, Brown A, Critchley HO, Williams AR, Lin S, Cheng L 2003 Effect of long-term treatment with low-dose mifepristone on the endometrium. Hum Reprod 18:61-68
7. Newfield RS, Spitz IM, Isacson C, New MI 2001 Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia. Clin Endocrinol (Oxf) 54:399-404
8. Murphy AA, Kettel LM, Morales AJ, Roberts V, Parmley T, Yen SS 1995 Endometrial effects of long-term low-dose administration of RU486. Fertil Steril 63:761-766
9. Eisinger SH, Meldrum S, Fiscella K, le Roux HD, Guzick DS 2003 Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol 101:243-250
10. Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD 1989 Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 52:1055-1060
11. Hodgen GD, van Uem JF, Chillik CF, Danforth DR, Wolf JP, Neulen J, Williams RF, Chwalisz K 1994 Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum Reprod 9(Suppl 1):77-81
12. van Uem JF, Hsiu JG, Chillik CF, Danforth DR, Ulmann A, Baulieu EE, Hodgen GD 1989 Contraceptive potential of RU 486 by ovulation inhibition. I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception 40:171-184
13. Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP 1995 Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception. Am J Obstet Gynecol 173:779-787
14. Zelinski-Wooten MB, Slayden OD, Chwalisz K, Hess DL, Brenner RM, Stouffer RL 1998 Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity. Hum Reprod 13:259-267
15. Croxatto HB, Kovacs L, Massai R, Resch BA, Fuentealba B, Salvatierra AM, Croxatto HD, Zalanyi S, Viski S, Krenacs L 1998 Effects of long-term low-dose mifepristone on reproductive function in women. Hum Reprod 13:793-798
16. Croxatto HB, Salvatierra AM, Croxatto HD, Fuentealba B 1993 Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod 8:201-207
17. Tanaka T, Umesaki N, Chen H, Mizuno K, Ogita S 1999 Danazol effects on human endometrial cells in vitro. Clin Exp Obstet Gynecol 26:67-70
18. Rose GL, Dowsett M, Mudge JE, White JO, Jeffcoate SL 1988 The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 49:224-228
19. Miller N, Bedard YC, Cooter NB, Shaul DL 1986 Histological changes in the genital tract in transsexual women following androgen therapy. Histopathology 10:661-669
20. Futterweit W, Deligdisch L 1986 Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 62:16-21
21. Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HO, Baird DT, Brenner RM 2001 Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86:2668-2679
22. Endl E, Gerdes J 2000 The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231-237
23. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715
24. Heikinheimo O, Hsiu JG, Gordon K, Kim S, Williams RF, Gibbons WE, Hodgen GD 1996 Endometrial effects of RU486 in primates: antiproliferative action despite signs of estrogen action and increased cyclin-B expression. J Steroid Biochem Mol Biol 59:179-190
25. Hall PA, Levison DA 1990 Review: assessment of cell proliferation in histological material. J Clin Pathol 43:184-192
26. Brenner RM, Slayden OD, Rodgers WH, Critchley HO, Carroll R, Nie XJ, Mah K 2003 Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum Reprod 18:1185-1193
27. Adams JL, Polson DW, Franks S 1986 Presence of polycystic ovaries in anovulatory women and patients with idiopathic hirsutism. Br Med J 243:355-359
28. Cameron ST, Glasier AF, Narvekar N, Gebbie A, Critchley HOD, Baird DT 2003 Effects of onapristone on postmenopausal endometrium. Steroids 68: 1053-1059
29. Wang H, Critchley HO, Kelly RW, Shen D, Baird DT 1998 Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4:407-412
30. Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT 2001 Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 86:1370-1378
31. Critchley HO, Kelly RW, Lea RG, Drudy TA, Jones RL, Baird DT 1996 Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 11: 2257-2262
32. Rumpel E, Michna H, Kuhnel W 1993 Morphology of the rat uterus after long-term treatment with progesterone antagonists. Anat Anz 175:141-149
33. Bigsby RM, Young PC 1994 Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus. Am J Obstet Gynecol 171:188-194
34. Chillik CF, Hsiu JG, Acosta AA, van Uem JF, Hodgen GD 1986 RU486-induced menses in cynomolgus monkeys: uniformity of endometrial sloughing. Fertil Steril 45:708-712
35. Ishwad PC, Katkam RR, Hinduja IN, Chwalisz K, Elger W, Puri CP 1993 Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys. Contraception 48:57-70
36. Koering MJ, Healy DL, Hodgen GD 1986 Morphologic response of endometrium to a progesterone receptor antagonist, RU486, in monkeys. Fertil Steril 45:280-287
37. Neulen J, Williams RF, Breckwoldt M, Chwalisz K, Baulieu EE, Hodgen GD 1996 Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum Reprod 11: 1533-1537
38. Slayden OD, Zelinski-Wooten MB, Chwalisz K, Stouffer RL, Brenner RM 1998 Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 13:269-277
39. Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS 1993 Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 76:513-517
40. Mertens HJ, Heineman MJ, Koudstaal J, Theunissen P, Evers JL 1996 Androgen receptor content in human endometrium. Eur J Obstet Gynecol Reprod Biol 70:11-13
41. Adesanya-Famuyiwa OO, Zhou J, Wu G, Bondy C 1999 Localization and sex steroid regulation of androgen receptor gene expression in rhesus monkey uterus. Obstet Gynecol 93:265-270
42. Slayden OD, Brenner RM 1994 RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 78:440-448
43. Neulen J, Williams RF, Hodgen GD 1990 RU 486 (mifepristone): induction of dose dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J Clin Endocrinol Metab 71:1074-1075
44. Danielsson KG, Swahn ML, Westlund P, Johannisson E, Seppala M, Bygdeman M 1997 Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum Reprod 12:124-131
45. Tuckerman EM, Okon MA, Li T, Laird SM 2000 Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74:771-779
46. Slayden OD, Brenner RM 2003 Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium. J Clin Endocrinol Metab 88:946-949
47. Attardi BJ, Burgenson J, Hild SA, Reel JR, Blye RP 2002 CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. Mol Cell Endocrinol 188:111-123
48. Fujimoto J, Nishigaki M, Hori M, Ichigo S, Itoh T, Tamaya T 1995 Biological implications of estrogen and androgen effects on androgen receptor and its mRNA levels in human uterine endometrium. Gynecol Endocrinol 9:149-155
49. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA 2002 Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66:297-304